The EKOS^™ Control Unit PT3b with Acoustic Pulse Thrombolysis^™ treatment is very unique. It uses targeted ultrasonic waves in combination with clot-dissolving drugs in the treatment of PE, DVT and PAO. The system uses a sophisticated catheter and an ultrasonic core to effectively target an entire clot.
 

Acoustic Pulse Thrombolysis^™

The EKOS^™ Control Unit PT3b with Acoustic Pulse Thrombolysis^™ technology thins a clot’s fibrous mesh called fibrin. The acoustic pulse field makes the fibrin more porous while creating a pressure gradient which transports the clot-dissolving drug deep inside the clot.

• Speeds time-to-clot dissolution.
• Results in quality clinical outcomes.
• Increases clot removal and enhances clinical improvement compared to either standard, catheter-directed drug therapy or thrombectomy.

Targets the Thrombus Safely

• Lowers the risk of bleeding and other complications.
• Dissolves clots without damaging vessels, valves or walls.

More Effective Drug Delivery

• Reduces dosage requirements by as much as 68% compared to standard, catheter-directed drug therapy.
• Requires up to 4x less drug dosage than traditional systemic delivery.

Superior Clot Clearance

• 48% greater drug absorption within 1 hour.
• 84% greater drug absorption within 2 hours.